Molecular Profile–Based Adjuvant Treatment in High-Intermediate Risk Endometrial Cancer The ASCO Post
Endometriosis is a widespread gynecological condition characterized by the presence of endometrial like tissue outside the uterine cavity. According to the literature, the frequency of endometriosis in adolescents remains unclear; …
Endometriosis is a chronic, debilitating condition characterized by heterogenous clinical manifestations. It has a prevalence of 5-10% in women of reproductive age, and 30-50% of individuals with endometriosis are affected …
Novel Small Molecule Inhibitors Show Efficacy in Endometrial Cancer Targeted Oncology
Endometriosis (EM) is an inflammatory condition that affects approximately 10% of the female-born population. It is characterized by the presence of endometrial tissue outside the uterine cavity, leading to chronic …
‘Guiding Light’ Soap Opera Actress Beth Chamberlin, 62, Says She Received a Hysterectomy After Endometrial Cancer Diagnosis – ‘I Didn’t Tell Anyone, Not Even My Family’ Until Now SurvivorNet
Acrivon Therapeutics Spotlights ACR368 Endometrial Cancer Data, Adds Serous Arm 3 and FDA Phase 3 Plan Defense World
Cell map offers insights into endometrial dysfunction in women with PCOS MSN
To investigate the impact of anti-endometrial antibodies (EMAb) on pregnancy outcomes in infertile patients undergoing in vitro fertilization (IVF) and to assess the potential value of personalized treatment strategies.
Endometriosis is an estrogen-dependent condition characterized by ectopic implantation of endometrial tissue, yet the molecular mechanisms underlying lesion persistence remain incompletely understood. Aquaporins (AQPs), transmembrane water channels involved in cellular …